Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orthopaedics sector shines

This article was originally published in Clinica

Executive Summary

Abbott Laboratories' diagnostic sales were $721 million in the quarter, down 4% on the previous year's second quarter. US hospital products sales were up 4% at $686 million, while international hospital products were $190 million, down slightly. The effects of foreign exchange continue to hit figures. The company says its diagnostic sales are expected to accelerate during the remainder of the year, with double-digit growth predicted in the fourth quarter. Growth rates for US hospital products in the second half and full year are similarly expected to be in double digits.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072166

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel